Peadar Tóibín (Meath West, Aontú)
Link to this: Individually | In context | Oireachtas source

625. To ask the Minister for Health if his attention has been drawn to any differential in survival rates for cancer between persons who were diagnosed in a public versus private hospital or clinic; and if a breakdown can be provided based on cancer type and survival rates in years, in tabular form. [14708/23]

Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

Successive National Cancer Strategies have delivered continuing improvements in outcomes for Irish cancer patients in terms of earlier diagnosis, better treatment, and improved rates of survival. This Government’s commitment to implementation of the National Cancer Strategy is evidenced by significant investment in recent years. €20m new development funding was allocated to cancer services and €15m was allocated for new cancer drugs in both 2021 and 2022. This increased total funding for cancer services to €139m in 2022.

The model of care for hospital cancer treatment is centred on eight Designated Cancer Centres serving a defined population and geographic area. The centralisation of specialist servicesinto Designated Cancer Centres aims to optimise patient outcomes, through case volume, multidisciplinary working and infrastructural supports.

The National Cancer Registry (NCRI) published a report in 2019, Cancer care and survival in relation to centralisation of Irish cancer services: an analysis of National Cancer Registry data 1994-2015. This report provides comparisons of five-year cancer-specific survival between three categories of hospitals (designated centres, other public hospitals, and private hospitals), based on where patients were first treated or diagnosed. Comparisons are made for cancers of the oesophagus, stomach, rectum, pancreas, lung, breast, prostate, and brain/central nervous system.

The report found that cause-specific survival of patients improved over time, both nationally and within most hospital categories, for the majority of the cancers and other tumours analysed. There were differences in survival rates between designated centres and private hospitals, depending on the cancer or tumour-type involved.

A number of factors may influence and help explain differences seen in survival, such as stage differences and, to a lesser degree, deprivation status of the patient. The report notes that differences in the appropriateness or quality of treatment and unmeasured differences in general patient health affecting suitability for treatment may contribute to survival differences between hospital categories.

It should be noted that all comparisons are based on hospital category, not on patient status, i.e. whether the patient's care is publicly funded or privately insured. Therefore, figures for cancer centres, and to a lesser extent other public hospitals, include any private patients whose first treatment/diagnosis was in a public hospital.

A full copy of the report including a summary table detailing cause-specific survival of cancer patients diagnosed 2008-2014, by category of hospital where first treated or diagnosed, can be viewed and downloaded from the NCRI: www.ncri.ie/sites/ncri/files/pubs/CancerCentralisation_NCRI_Jan2019_fullreport_29012019_final.pdf